Laresin Plus

Olmesartan medoxomil and hydrochlorothiazide, the active ingredients in Laresin Plus, are an angiotensin II receptor blocker and a thiazide diuretic presented as oral tablets for systemic use. They treat hypertension in adult patients by lowering elevated blood pressure through complementary mechanisms that reduce vascular resistance and plasma volume.

GNH USA supplies Laresin Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across global markets.

Laresin Plus combines an angiotensin II receptor blocker with a thiazide diuretic to manage hypertension.

Essential hypertension: reduces systolic and diastolic blood pressure in patients with primary hypertension. Renal hypertension: assists in blood pressure control in patients whose hypertension is secondary to renal disease. Diastolic hypertension: helps achieve target diastolic pressure in patients with elevated diastolic readings.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urinary frequency - Mild electrolyte changes (e.g., low potassium) - Dry mouth or mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis - Angioedema (swelling of face, lips, tongue) - Significant electrolyte disturbances such as hyperkalemia or hyponatremia - Acute renal impairment or sudden rise in serum creatinine - Pancreatitis - Marked hypotension leading to fainting

Before initiating therapy, consider the following precautions.

Renal function: assess kidney function and monitor creatinine regularly. Electrolytes: check serum potassium and sodium levels periodically. Pregnancy: avoid use unless the potential benefit justifies the risk. Elderly patients: start at a lower dose and monitor for orthostatic hypotension. Drug interactions: review all concomitant medicines for possible interactions. Store at ambient temperature: keep in the original container, protect from moisture and light.

Laresin Plus may interact with several medicines; monitor as indicated.

Major Interactions (Avoid): - Potassium‑sparing diuretics or potassium supplements: risk of hyperkalemia. - ACE inhibitors or other ARBs: additive blood‑pressure lowering and possible renal impairment. - Lithium: increased lithium concentrations and toxicity.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance hypotensive effect. - Calcium channel blockers: additive blood‑pressure reduction. - Antidiabetic agents: blood‑glucose levels may change, requiring dose adjustment.